Mek ICS Co., Ltd. implemented “DUAL HFV”, the treatment technology for patients with dyspnea

SEONGNAM--(Korea Newswire)--Mek ICS Co., Ltd.,(CEO Jong-Cheol Kim, www.mek-ics.com) company specialized in medical equipment, is attracting attentions with “HFV”, which is a new breathing treatment of mechanical ventilation to improving the purpose of treatment while minimizing lung injury of patients with lung disease, such as difficulty in breathing, etc.

“HFV (High Frequency Ventilation)”, also called as high frequency ventilation equipment, is the method of mechanical breathing to help to maintain the pulmonary respiration in small amount of oxygen by making patients breathe through fast ventilation on an average of 300 to 1,200 times per minute.

Since an amount of single breath is very small and inspiratory time is very short, the diffusion process in the lungs and the continuous flow of air are actively carried out. Thus, it can restore alveolar better than the treatment by injecting a mass amount of air (high pressure), and it can also reduce lung injury with less pressure variation range.

The reason why Mek ICS Co., Ltd.’s “HFV” technology gets more interests is the “DUAL HFV” mode. It is the function to measure CO2 in the lungs which are discharged at the time of breathing when giving a little of exhaust time during the time of oxygen supply.

The measurement of CO2 emission is necessary to accurately grasp the condition of neonatal and obese patients whose oxygen saturation level and apnea during sleep are low.

“HFV” technology is effective in treatment for patients of pneumothorax of interstitial lung, pneumonia, refractory hypoxemia, sepsis, suffocation, acute respiratory distress syndrome (ARDS) and chronic obstructive disease (COPD).

“Chronic obstructive disease is a high-risk disease with the 4th highest mortality rate in the world and the 7th highest mortality rate in Korea, thereby, requiring a safe treatment with great cares,” Min Wang Kim, director of Mek ICS Co., Ltd., said. “’HFV’, the technology of Ventilator aid treatment, is employed by Draeger of Germany and Metran of Japan as well as ‘SU:M 3’ that is our second generation Ventilator.

Since “SU:M 3” does not require piston block devices unlike the other companies’ products, it could enhance economic efficiency and durability. And also it is possible to use common accessories due to the type of the company's patent application.

Website: http://www.mek-ics.com

This is a news release distributed by Korea Newswire on behalf of this company.